Novo Nordisk shares jump 7% as drugmaker sees copycat Wegovy sales easing in 2025

Novo Nordisk on Wednesday reported a better-than-expected rise in net profit but lowered its full-year sales growth forecast.

Leave a Reply

Your email address will not be published. Required fields are marked *